WO2011161229A1 - Process for producing microcapsules - Google Patents

Process for producing microcapsules Download PDF

Info

Publication number
WO2011161229A1
WO2011161229A1 PCT/EP2011/060599 EP2011060599W WO2011161229A1 WO 2011161229 A1 WO2011161229 A1 WO 2011161229A1 EP 2011060599 W EP2011060599 W EP 2011060599W WO 2011161229 A1 WO2011161229 A1 WO 2011161229A1
Authority
WO
WIPO (PCT)
Prior art keywords
consumer product
microcapsules
isocyanates
product according
isocyanate
Prior art date
Application number
PCT/EP2011/060599
Other languages
French (fr)
Inventor
Jutta Hotz
Wolfgang Denuell
Original Assignee
Givaudan Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givaudan Sa filed Critical Givaudan Sa
Priority to MX2012013822A priority Critical patent/MX2012013822A/en
Priority to JP2013515906A priority patent/JP6078464B2/en
Priority to BR112012033017-9A priority patent/BR112012033017B1/en
Priority to EP11729951.1A priority patent/EP2585028B1/en
Priority to US13/699,419 priority patent/US20130089590A1/en
Priority to ES11729951.1T priority patent/ES2602440T3/en
Priority to KR1020137001659A priority patent/KR101833084B1/en
Priority to CN201180028710XA priority patent/CN102958497A/en
Publication of WO2011161229A1 publication Critical patent/WO2011161229A1/en
Priority to ZA2012/09124A priority patent/ZA201209124B/en
Priority to US14/560,700 priority patent/US20150140050A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/50Perfumes
    • C11D3/502Protected perfumes
    • C11D3/505Protected perfumes encapsulated or adsorbed on a carrier, e.g. zeolite or clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11Encapsulated compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8176Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/12Preparations containing hair conditioners
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • B01J13/06Making microcapsules or microballoons by phase separation
    • B01J13/14Polymerisation; cross-linking
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • B01J13/06Making microcapsules or microballoons by phase separation
    • B01J13/14Polymerisation; cross-linking
    • B01J13/16Interfacial polymerisation
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/0039Coated compositions or coated components in the compositions, (micro)capsules
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/26Organic compounds containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/38Products with no well-defined composition, e.g. natural products
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/50Perfumes
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D7/00Compositions of detergents based essentially on non-surface-active compounds
    • C11D7/22Organic compounds
    • C11D7/32Organic compounds containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D7/00Compositions of detergents based essentially on non-surface-active compounds
    • C11D7/22Organic compounds
    • C11D7/40Products in which the composition is not well defined
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D9/00Compositions of detergents based essentially on soap
    • C11D9/04Compositions of detergents based essentially on soap containing compounding ingredients other than soaps
    • C11D9/22Organic compounds, e.g. vitamins
    • C11D9/30Organic compounds, e.g. vitamins containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D9/00Compositions of detergents based essentially on soap
    • C11D9/04Compositions of detergents based essentially on soap containing compounding ingredients other than soaps
    • C11D9/22Organic compounds, e.g. vitamins
    • C11D9/38Products in which the composition is not well defined
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D9/00Compositions of detergents based essentially on soap
    • C11D9/04Compositions of detergents based essentially on soap containing compounding ingredients other than soaps
    • C11D9/44Perfumes; Colouring materials; Brightening agents ; Bleaching agents
    • C11D9/442Perfumes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/412Microsized, i.e. having sizes between 0.1 and 100 microns
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/61Surface treated
    • A61K2800/62Coated
    • A61K2800/624Coated by macromolecular compounds
    • C11D2111/12

Definitions

  • the application relates to a process for producing microcapsules, and to uses of those microparticles in consumer products.
  • Microcapsules are powders or particles which consist of a core and a wall material surrounding the core, wherein the core is a solid, liquid or gaseous substance which is surrounded by the solid, generally polymeric, wall material. They may be solid, i.e. consist of a single material. Microcapsules have on average a diameter from 1 to 1000 pm.
  • the shell can consist either of natural, semisynthetic or synthetic materials.
  • Natural shell materials are, for example, gum arable, agar agar, agarose, maltodextrins, alginic acid or its salts, e.g. sodium alginate or calcium alginate, fats and fatty acids, cetyl alcohol, collagen, chitosan, lecithins, gelatin, albumin, shellac, polysaccharides, such as starch or dextran, polypeptides, protein hydrolyzates, sucrose and waxes.
  • Semisynthetic shell materials are inter alia chemically modified celluloses, in particular cellulose esters and cellulose ethers, e.g.
  • Synthetic shell materials are, for example, polymers such as polyacrylates, polyamides, polyvinyl alcohol or polyvinylpyrrolidone.
  • microcapsules are formed in each case with different properties as far as diameter, size
  • a first subject matter of the present application is therefore directed to a process for producing microcapsules which contain a shell and a fragrance oil core, where an aqueous solution of a protective colloid and a solution of a mixture of at least two structurally different at least difunctional isocyanates (A) and (B) in said oil are brought together until an emulsion is formed, to which an at least difunctional amine is then added, and which is then heated to temperatures of at least 60°C until the microcapsules are formed, wherein the isocyanate (B) is selected from the anionically modified isocyanates or from polyethylene oxide-containing isocyanates or mixtures of these types and the isocyanate (A) is uncharged, but is not a polyethylene-containing isocyanate.
  • the process has the advantage that microcapsules of a pre-given size or size distribution can be produced in a targeted manner, it being possible here to produce in particular relatively small microcapsules with diameters from 10 to 60 ⁇ . Moreover, capsules with greater mechanical stability are obtained. Here, in particular those capsules are obtained, the shells of which have only a low permeability to the liquid ingredients.
  • an aqueous solution of the protective colloid is always produced, and for this the isocyanates (A) and (B) are dissolved in the fragrance oil, which later forms the core of the microcapsules; the amine components are then added and the mixture is heated until an emulsion is formed.
  • the temperature for the reaction of the isocyanates with the amine components must be at least 60°C, but better 70°C, but preferably 75 to 90°C and in particular 85 to 90°C, in order to ensure sufficiently rapid reaction progress.
  • the temperature in stages e.g. in each case by 10°C
  • the dispersion is cooled to room temperature (21 °C).
  • the reaction time typically depends on the amounts and temperatures used. Usually, however, the elevated temperature for forming the microcapsules is established between ca. 60 minutes to 6 h or up to 8 h.
  • the addition of the amine also preferably takes place with the input of energy, e.g. by using a stirring apparatus.
  • the respective mixtures are emulsified by processes known to the person skilled in the art, e.g. by introducing energy into the mixture through stirring using a suitable stirrer until the mixture emulsifies.
  • the pH is preferably adjusted using aqueous bases, preference being given to using sodium hydroxide solution (e.g. 5% strength by weight).
  • the process is carried out as follows:
  • a premix (I) is prepared from water and a protective colloid
  • this premix is adjusted to a pH in the range from 5 to 12; (c) a further premix (II) is prepared from the fragrance oil together with the
  • step (e) the at least difunctional amine is then metered into the emulsion from step (d) and
  • the emulsion is then heated to temperatures of at least 60°C until the microcapsules are formed.
  • step (b) It may be advantageous to adjust the pH in step (b) to values from 8 to 12.
  • aqueous bases preferably aqueous sodium hydroxide solution.
  • step (e) is preferably ensured by using a suitable stirrer.
  • a premix (I) is prepared from water and a protective colloid
  • this premix is adjusted to a pH in the range from 5 to 12;
  • a further premix (II) is prepared from a fragrance oil with the isocyanate (A);
  • an emulsion is formed from the premixes (I) and (II) by stirring and to this (e) is added the second isocyanate (B), and then the pH of the emulsion is adjusted to a value from 5 to 10;
  • step (f) and then the at least difunctional amine is metered into the emulsion from step (e) and (g) then heated to temperatures of at least 60°C until the microcapsules are formed.
  • the isocyanates (A) and (B) are added separately to the protective colloid before the addition of the amine and the reaction to give the microcapsules takes place.
  • the formation of the emulsion - like the mixing in step (e) also takes place here preferably by using a stirring apparatus.
  • step (e) is preferably adjusted to values from 7.5 to 9.0.
  • step (b) the value can likewise be adjusted from 8 to 12.
  • aqueous bases preferably aqueous sodium hydroxide solution.
  • the microcapsules have a shell made of a reaction product of at least two different, at least difunctional isocyanates with amines, preferably with polyamines.
  • the reaction is a polycondensation between the isocyanates and the amines, which leads to a polyurea derivative.
  • the microcapsules may be present in the form of aqueous dispersions, the weight fraction of these dispersions in the capsules being preferably between 15 and 45% by weight and preferably 20 to 40% by weight.
  • the microcapsules have an average diameter in the range from 1 to 500 pm and preferably from 1 to 50 pm or from 5 to 25 pm.
  • the amount of fragrance oil can vary in the range from 10 to 95% by weight, based on the weight of the capsules, where fractions from 70 to 90% by weight may be advantageous.
  • capsules are obtained which typically have core/shell ratios (w/w) from 20:1 to 1 :10, preferably from 5:1 to 2:1 and in particular from 4:1 to 3:1.
  • the microcapsules which are produced by the present process are preferably free from formaldehyde.
  • a protective colloid During the reaction between the isocyanates and the amines, a protective colloid must be present.
  • This is preferably a polyvinylpyrrolidone (PVP).
  • PVP polyvinylpyrrolidone
  • Protective colloids are polymer systems which, in suspensions or dispersions, prevent a clumping together (agglomeration, coagulation, flocculation) of the emulsified, suspended or dispersed substances. During solvation, protective colloids bind large amounts of water and in aqueous solutions produce high viscosities depending on the concentration. Within the context of the process described herein, the protective colloid may also have emulsifying properties.
  • the aqueous protective colloid solution is likewise preferably prepared with stirring.
  • the protective colloid may be, but does not have to be, a constituent of the capsule shell, with amounts from 0.1 to at most 15% by weight, but preferably in the range from 1 to 5% by weight and in particular from 1.5 to 3% by weight, based on the weight of the capsules, being possible here.
  • Organic isocyanates are compounds in which the isocyanate group (-NOO) is bonded to an organic radical.
  • Polyfunctional isocyanates are those compounds with two or more isocyanate groups in the molecule.
  • At least difunctional, preferably polyfunctional, isocyanates are used, i.e. all aromatic, alicyclic and aliphatic isocyanates are suitable provided they have at least two reactive isocyanate groups.
  • Suitable isocyanates are, for example, 1 ,5-naphthylene diisocyanate,
  • TDI tolylene diisocyanate
  • TDI tolylene diisocyanate
  • 1-methyl-2,4-diisocyanatocyclohexane 1,6-diisocyanato-2,2,4-trimethylhexane
  • 1 ,6-diisocyanato-2,4,4-trimethylhexane 1,6-diisocyanato-2,4,4-trimethylhexane
  • chlorinated and brominated diisocyanates phosphorus- containing diisocyanates
  • 4,4'-diisocyanatophenylperfluoroethane 1,4'-diisocyanatophenylperfluoroethane
  • HDI 1,6-diisocyanate
  • 1 ,4-diisocyanate ethylene diisocyanate, phthalic acid bisisocyanatoethyl ester, also polyisocyanates with reactive halogen atoms, such as 1-chloromethylphenyl 2,4-diisocyanate, 1-bromomethylphenyl 2,6-diisocyanate, 3,3-bischloromethyl ether 4,4'-diphenyldiisocyanate.
  • Sulfur-containing polyisocyanates are obtained, for example, by reacting 2 mol of hexamethylene diisocyanate with 1 mol of
  • diisocyanates are trimethylhexamethylene diisocyanate, 1 ,4-diisocyanatobutane,
  • Suitable isocyanates of type (A) are at least difunctional compounds (i.e.
  • Typical representatives may be hexamethylene diisocyanate (HDI), or derivatives thereof, e.g. HDI biuret (commercially available e.g. as Desmodur N3200), HDI trimers ⁇ commercially available as Desmodur N3300) or else dicyc!ohexylmethane diisocyanates (commercially available as Desmodur W). Toluene 2,4-diisocyanate or diphenylmethane diisocyanate is likewise suitable.
  • HDI hexamethylene diisocyanate
  • HDI biuret commercially available e.g. as Desmodur N3200
  • HDI trimers ⁇ commercially available as Desmodur N3300
  • Desmodur W dicyc!ohexylmethane diisocyanates
  • Toluene 2,4-diisocyanate or diphenylmethane diisocyanate is likewise suitable.
  • the second isocyanate of type (B) is structurally different from the isocyanate of type (A) and specifically the isocyanate of type (B) must either be an anionically modified isocyanate or a polyethylene oxide-containing isocyanate (or any desired mixtures of these two isocyanate types).
  • anionically modified isocyanates are known per se.
  • these isocyanates of type (B) contain at least two isocyanate groups in the molecule.
  • One or more sulfonic acid radicals are preferably present as anionic groups.
  • isocyanates of type (B) are selected which are oligomers, in particular trimers, of hexane 1 ,6-diisocyanate (HDl).
  • Commercial products of these anionically modified isocyanates are known, for example, under the brand Bayhydur (Bayer), e.g.
  • Bayhydur XP Polyethylene oxide-containing isocyanates (with at least two isocyanate groups) are also known and are described, e.g. in US 5,342,556. Some of these
  • isocyanates are self-emulsifying in water, which may be advantageous within the context of the present process since it may be possible to dispense with a separate emulsifying step.
  • the weight ratio of the two isocyanates (A) and (B) is adjusted preferably in the range from 10:1 to 1 :10, but in particular in the range from 5:1 to 1 :5 and in particular in the range from 3:1 to 1 :1.
  • anionically modified isocyanates are used as component (B) in the present process.
  • At least difunctional amines but preferably polyethyleneimines (PEI), are used as further component in the process according to the invention.
  • PEI polyethyleneimines
  • Polyethyleneimines are generally polymers in the main chains of which there are NH groups which are separated from one another in each case by two methylene groups:
  • polyethyleneimines with a molecular weight of at least 500 g/mol, preferably from 600 to 30 000 or 650 to 25 000 g/mol and in particular from 700 to 5000 g/mol or 850 to 2500 g/mol, are preferably used.
  • PVP is used as protective colloid.
  • PVP is the abbreviation for polyvinylpyrrolidones (also known as polyvidone). According to Rompp Chemie Lexikon, Online-edition 3.6, 2010, they are [poly ⁇ 1-vinylpyrrolidin- 2-ones)], i.e. polymers (vinyl polymers) which conform to the general formula:
  • Standard commercial polyvinylpyrrolidones have molar masses in the range from ca. 2500-750 000 g/mol which are characterized by stating the K values and have - depending on the K value - glass transition temperatures from 130 to 175°C. They are supplied as white, hygroscopic powders or as aqueous solution.
  • PVPs with a high molecular weight, i.e. more than 400 000 g/mol and preferably from
  • the polyvinylpyrrolidones prefferably have a K value of more than 60, preferably more than 75 and in particular more than 80.
  • a preferred range is between 65 and 90 for the K value.
  • the microcapsules produced using the process described above contain a fragrance oil core.
  • the isocyanates should be soluble in the oil forming the core
  • fragment oil denotes one or a mixture of perfume components, optionally mixed with a suitable solvent, diluent, carrier or other adjuvant, which is intended to be used to impart a desired odour to a consumer product.
  • perfume components and mixtures thereof which can be used for the preparation of such fragrance oils may include natural products such as essential oils, absolutes, resinoids, resins, concretes, etc., and synthetic perfume
  • perfume components are: geraniol, geranyl acetate, linalool, linalyl acetate, tetrahydrolinalool, citronelloi, citronellyl acetate, dihydromyrcenol, dihydromyrcenyl acetate, tetrahydromyrcenol, terpineol, terpinyl acetate, nopol, nopyl acetate, 2- phenylethanol, 2-phenylethyl acetate, benzyl alcohol, benzyl acetate, benzyl salicylate, benzyl benzoate, styrallyl acetate, amy! salicylate,
  • dimethylbenzylcarbinol dimethylbenzylcarbinol, trichloromethylphenycarbinyl acetate, p-tert.butylcyclohexyl acetate, isononyl acetate, vetiveryl acetate, vetiverol, alpha-n-amylcinammic aldehyde, alpha-hexylcinammic aldehyde, 2-methyl-3-(p-tert.butylphenyl)propanal, 2-methyl-3-(p-isopropylphenyl)propanal, 3-(p-tert.butylphenyi)propanal,
  • fragrances ethylene brassylate, aromatic nitromusk fragrances.
  • the fragrance oils may also contain precursor or pro-fragrances of any perfume ingredients including any of those mentioned specifically above.
  • Suitable solvents, diluents or carriers for perfumes as mentioned above are for example: ethanol, isopropanol, diethylene glycol monoethyl ether, dipropylene glycol, diethyl phthalate, triethyl citrate and the like.
  • carrier materials, diluents, solvents and other auxiliary agents commonly used in conjunction with fragrance oils can be found in, for example, in S. Arctander, 'Perfume and Flavour Materials of Natural Origin', Elizabeth, N.J., 1960, S. Arctander, 'Perfume and Flavour Chemicals', Vol. I and II, Allured Publishing Corporation, Carol Stream, 1994, and J.M. Nikitakis (Ed.), 'CTFA Cosmetic Ingredient Handbook, 1st ed., The Cosmetic, Toiletry and Fragrance Association, Inc., Washington, 1988.
  • the invention further provides aqueous dispersions comprising 5 to 50% by weight, based on the total weight of the dispersion, preferably from 15 to 40% by weight, of microcapsules which can be produced by the above process. A further preferred range is between 20 and 35% by weight.
  • microcapsule dispersions which are obtained by the present process can be used to perfume all manner of consumer products.
  • An exhaustive list of consumer products cannot be given here and the skilled person would appreciate the scope of application for such microcapsules.
  • Illustrative examples of consumer products include all laundry applications including softeners, liquid detergents, and powder detergents; all personal care and hair care applications including shampoo, conditioners, combing creams, leave on conditioners, styling cream, soaps, body creams and the like; deodorants and anti-perspirants; and all household cleaning applications.
  • the present invention further provides preferably formaldehyde-free microcapsules containing a fragrance oil core, and a shell of a reaction product of at least two different at least difunctional isocyanates (A) and (B), where the isocyanate (B) must be an anionically modified isocyanate or a polyethylene oxide containing isocyanate or mixtures of the types, and an at least difunctional amine, with the proviso that during the production of the microcapsules the weight ratio between the isocyanates (A) and (B) is in the range from 10:1 to 1 :10.
  • the aforementioned weight ratios can be adjusted, where the ratio from 3:1 to 1 :1 may be attributed particular importance.
  • microcapsules preferably have diameters from 1 to 50 ⁇ and preferably diameters from 2 to 45 ⁇ . They may be present in the form of an aqueous dispersion, where the fraction of the capsules can be 1 to 90% by weight, but preferably 5 to 50% by weight.
  • An oil phase was prepared when Desmodur W (Bayer) and Bayhydur XP2547 (Bayer) were added in perfume oil at a level of 2.6% and 3.4% respectively.
  • aqueous phase (Solution S2) was prepared by adding Lupasol PR8515 (BASF) to water, at a level of 20%.
  • Capsules were prepared according to the following procedure:
  • 300g of the oil phase was mixed with 600g of solution S1 , to form an oil-in-water emulsion, in a 1L reactor equipped with a MIG stirrer operating at 10OOrpm.After 30 minutes of mixing, 10Og of solution S2 was added over a period of 1 minute.After 30 minutes, the slurry was heated up to 70°C (1 H), then kept for 2H at 70°C, then heated to 80°C and kept for 1 H at 80°C, then heated to 85°C and kept for 1 H at 85°C, then cooled to 70°C and kept for 1 H at 70°C before final cooling at 25°C.
  • Hair Switch testing was carried out using standard hair protocols with a dosage of perfume of 0.2%.
  • the capsules were prepared according to recipe given in example 1.
  • the perfume composition is given in Table below.
  • the performance of the capsules was evaluated by a direct comparison with the free perfume (non encapsulated oil).
  • Example 3 Fabric Care Application
  • the capsules were prepared according to recipe given in Example 1.
  • the perfume composition is given in Table below.
  • the performance of the capsules was evaluated by a direct comparison with the free perfume (non encapsulated oil), on freshly prepared samples and after 1 month storage at 37°C. %
  • Washing conditions 100g of perfumed powder detergent, 1kg of cotton toweis, European washing machine.
  • the perfumed samples were prepared at a level of 0.5% perfume in a standard powder detergent base and the washing conditions used were as follows:

Abstract

The application describes a process for producing microcapsules which contain a shell made of polyurea and which surround in their interior a fragrance oil core, where the shell is obtained by the reaction of two structurally different diisocyanates in emulsion form.

Description

PROCESS FOR PRODUCING MICROCAPSULES
The application relates to a process for producing microcapsules, and to uses of those microparticles in consumer products.
Microcapsules are powders or particles which consist of a core and a wall material surrounding the core, wherein the core is a solid, liquid or gaseous substance which is surrounded by the solid, generally polymeric, wall material. They may be solid, i.e. consist of a single material. Microcapsules have on average a diameter from 1 to 1000 pm.
A multitude of shell materials is known for producing microcapsules. The shell can consist either of natural, semisynthetic or synthetic materials. Natural shell materials are, for example, gum arable, agar agar, agarose, maltodextrins, alginic acid or its salts, e.g. sodium alginate or calcium alginate, fats and fatty acids, cetyl alcohol, collagen, chitosan, lecithins, gelatin, albumin, shellac, polysaccharides, such as starch or dextran, polypeptides, protein hydrolyzates, sucrose and waxes. Semisynthetic shell materials are inter alia chemically modified celluloses, in particular cellulose esters and cellulose ethers, e.g. cellulose acetate, ethyl cellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose and carboxy- methylcellulose, and also starch derivatives, in particular starch ethers and starch esters. Synthetic shell materials are, for example, polymers such as polyacrylates, polyamides, polyvinyl alcohol or polyvinylpyrrolidone.
Depending on the type of shell material and the production process, microcapsules are formed in each case with different properties as far as diameter, size
distribution and physical and/or chemical properties are concerned.
There is therefore a continuing need to develop novel production processes in order to be able to provide microcapsules with tailored properties.
A first subject matter of the present application is therefore directed to a process for producing microcapsules which contain a shell and a fragrance oil core, where an aqueous solution of a protective colloid and a solution of a mixture of at least two structurally different at least difunctional isocyanates (A) and (B) in said oil are brought together until an emulsion is formed, to which an at least difunctional amine is then added, and which is then heated to temperatures of at least 60°C until the microcapsules are formed, wherein the isocyanate (B) is selected from the anionically modified isocyanates or from polyethylene oxide-containing isocyanates or mixtures of these types and the isocyanate (A) is uncharged, but is not a polyethylene-containing isocyanate.
The process has the advantage that microcapsules of a pre-given size or size distribution can be produced in a targeted manner, it being possible here to produce in particular relatively small microcapsules with diameters from 10 to 60 μητι. Moreover, capsules with greater mechanical stability are obtained. Here, in particular those capsules are obtained, the shells of which have only a low permeability to the liquid ingredients.
In principle, an aqueous solution of the protective colloid is always produced, and for this the isocyanates (A) and (B) are dissolved in the fragrance oil, which later forms the core of the microcapsules; the amine components are then added and the mixture is heated until an emulsion is formed. The temperature for the reaction of the isocyanates with the amine components must be at least 60°C, but better 70°C, but preferably 75 to 90°C and in particular 85 to 90°C, in order to ensure sufficiently rapid reaction progress.
Here, it may be preferred to increase the temperature in stages (e.g. in each case by 10°C) until then, following completion of the reaction, the dispersion is cooled to room temperature (21 °C). The reaction time typically depends on the amounts and temperatures used. Usually, however, the elevated temperature for forming the microcapsules is established between ca. 60 minutes to 6 h or up to 8 h.
According to the present teaching, the addition of the amine also preferably takes place with the input of energy, e.g. by using a stirring apparatus.
In order to form an emulsion in the present process, the respective mixtures are emulsified by processes known to the person skilled in the art, e.g. by introducing energy into the mixture through stirring using a suitable stirrer until the mixture emulsifies. The pH is preferably adjusted using aqueous bases, preference being given to using sodium hydroxide solution (e.g. 5% strength by weight). It is essential to the process that at least two structurally different isocyanates (A) and (B) are used. These can be added in the form of a mixture or separately from one another in the process to the aqueous premix (1 ) containing the protective colloid and are then emulsified and reacted with the amine. It is also conceivable to meter in both mixtures of (A) and (B), and also the individual isocyanates (A) and (B) separately at different times.
In one preferred embodiment, the process is carried out as follows:
(a) a premix (I) is prepared from water and a protective colloid;
(b) this premix is adjusted to a pH in the range from 5 to 12; (c) a further premix (II) is prepared from the fragrance oil together with the
isocyanates (A) and (B);
(d) the two premixes (I) and (II) are brought together until an emulsion is formed and
(e) the at least difunctional amine is then metered into the emulsion from step (d) and
(f) the emulsion is then heated to temperatures of at least 60°C until the microcapsules are formed.
It may be advantageous to adjust the pH in step (b) to values from 8 to 12. Of suitability here are aqueous bases, preferably aqueous sodium hydroxide solution. The formation of the emulsion in step (d), but also step (e) is preferably ensured by using a suitable stirrer.
Another likewise preferred embodiment envisages that
(a) a premix (I) is prepared from water and a protective colloid;
(b) this premix is adjusted to a pH in the range from 5 to 12; (c) a further premix (II) is prepared from a fragrance oil with the isocyanate (A); (d) an emulsion is formed from the premixes (I) and (II) by stirring and to this (e) is added the second isocyanate (B), and then the pH of the emulsion is adjusted to a value from 5 to 10;
(f) and then the at least difunctional amine is metered into the emulsion from step (e) and (g) then heated to temperatures of at least 60°C until the microcapsules are formed.
In this procedure, the isocyanates (A) and (B) are added separately to the protective colloid before the addition of the amine and the reaction to give the microcapsules takes place. The formation of the emulsion - like the mixing in step (e) also takes place here preferably by using a stirring apparatus.
The pH in step (e) is preferably adjusted to values from 7.5 to 9.0. For step (b), the value can likewise be adjusted from 8 to 12. Of suitability for this purpose are in particular aqueous bases, preferably aqueous sodium hydroxide solution.
Microcapsules Within the context of the present teaching, the microcapsules have a shell made of a reaction product of at least two different, at least difunctional isocyanates with amines, preferably with polyamines. The reaction is a polycondensation between the isocyanates and the amines, which leads to a polyurea derivative.
The microcapsules may be present in the form of aqueous dispersions, the weight fraction of these dispersions in the capsules being preferably between 15 and 45% by weight and preferably 20 to 40% by weight. The microcapsules have an average diameter in the range from 1 to 500 pm and preferably from 1 to 50 pm or from 5 to 25 pm.
The amount of fragrance oil can vary in the range from 10 to 95% by weight, based on the weight of the capsules, where fractions from 70 to 90% by weight may be advantageous. As a result of the process, capsules are obtained which typically have core/shell ratios (w/w) from 20:1 to 1 :10, preferably from 5:1 to 2:1 and in particular from 4:1 to 3:1. The microcapsules which are produced by the present process are preferably free from formaldehyde.
Protective colloid
During the reaction between the isocyanates and the amines, a protective colloid must be present. This is preferably a polyvinylpyrrolidone (PVP). Protective colloids are polymer systems which, in suspensions or dispersions, prevent a clumping together (agglomeration, coagulation, flocculation) of the emulsified, suspended or dispersed substances. During solvation, protective colloids bind large amounts of water and in aqueous solutions produce high viscosities depending on the concentration. Within the context of the process described herein, the protective colloid may also have emulsifying properties. The aqueous protective colloid solution is likewise preferably prepared with stirring.
The protective colloid may be, but does not have to be, a constituent of the capsule shell, with amounts from 0.1 to at most 15% by weight, but preferably in the range from 1 to 5% by weight and in particular from 1.5 to 3% by weight, based on the weight of the capsules, being possible here.
Isocyanates
Isocyanates are N-substituted organic derivatives (R-N=C=0) of isocyanic acid (HNCO) tautomeric in the free state with cyanic acid. Organic isocyanates are compounds in which the isocyanate group (-NOO) is bonded to an organic radical. Polyfunctional isocyanates are those compounds with two or more isocyanate groups in the molecule.
According to the invention, at least difunctional, preferably polyfunctional, isocyanates are used, i.e. all aromatic, alicyclic and aliphatic isocyanates are suitable provided they have at least two reactive isocyanate groups.
The suitable polyfunctional isocyanates preferably contain on average 2 to at most 4 NCO groups. Preference is given to using diisocyanates, i.e. esters of isocyanic acid with the general structure O=C=N-R-N=C=O, where R' here is aliphatic, alicyclic or aromatic radicals. Suitable isocyanates are, for example, 1 ,5-naphthylene diisocyanate,
4,4'-diphenylmethane diisocyanate (MOI), hydrogenated MDI (H12MDI), xylylene diisocyanate (XD(), tetramethylxylol diisocyanate (TMXDI), 4,4'-diphenyl- dimethylmethane diisocyanate, di- and tetraalkyldiphenylmethane diisocyanate, 4,4'-dibenzyl diisocyanate, 1 ,3-phenyiene diisocyanate, 1 ,4-phenylene
diisocyanate, the isomers of tolylene diisocyanate (TDI), optionally in a mixture, 1-methyl-2,4-diisocyanatocyclohexane, 1 ,6-diisocyanato-2,2,4-trimethylhexane, 1 ,6-diisocyanato-2,4,4-trimethylhexane, 1-isocyanatomethyl-3-isocyanato-1 ,5,5- trimethylcyc!ohexane, chlorinated and brominated diisocyanates, phosphorus- containing diisocyanates, 4,4'-diisocyanatophenylperfluoroethane,
tetramethoxybutane 1 ,4-diisocyanate, butane 1 ,4-diisocyanate, hexane
1 ,6-diisocyanate (HDI), dicyclohexyl methane diisocyanate, cyclohexane
1 ,4-diisocyanate, ethylene diisocyanate, phthalic acid bisisocyanatoethyl ester, also polyisocyanates with reactive halogen atoms, such as 1-chloromethylphenyl 2,4-diisocyanate, 1-bromomethylphenyl 2,6-diisocyanate, 3,3-bischloromethyl ether 4,4'-diphenyldiisocyanate. Sulfur-containing polyisocyanates are obtained, for example, by reacting 2 mol of hexamethylene diisocyanate with 1 mol of
thiodiglycol or dihydroxydihexyl sulfide. Further suitable diisocyanates are trimethylhexamethylene diisocyanate, 1 ,4-diisocyanatobutane,
1 ,2-diisocyanatododecane and dimer fatty acid diisocyanate.
One essential feature of the present process is the obligatory use of two
structurally different isocyanates (A) and (B).
Suitable isocyanates of type (A) are at least difunctional compounds (i.e.
compounds containing at least two isocyanate groups -N=C=O). Typical representatives may be hexamethylene diisocyanate (HDI), or derivatives thereof, e.g. HDI biuret (commercially available e.g. as Desmodur N3200), HDI trimers {commercially available as Desmodur N3300) or else dicyc!ohexylmethane diisocyanates (commercially available as Desmodur W). Toluene 2,4-diisocyanate or diphenylmethane diisocyanate is likewise suitable. The second isocyanate of type (B) is structurally different from the isocyanate of type (A) and specifically the isocyanate of type (B) must either be an anionically modified isocyanate or a polyethylene oxide-containing isocyanate (or any desired mixtures of these two isocyanate types).
The anionically modified isocyanates are known per se. Preferably, these isocyanates of type (B) contain at least two isocyanate groups in the molecule. One or more sulfonic acid radicals are preferably present as anionic groups. Preferably, isocyanates of type (B) are selected which are oligomers, in particular trimers, of hexane 1 ,6-diisocyanate (HDl). Commercial products of these anionically modified isocyanates are known, for example, under the brand Bayhydur (Bayer), e.g.
Bayhydur XP. Polyethylene oxide-containing isocyanates (with at least two isocyanate groups) are also known and are described, e.g. in US 5,342,556. Some of these
isocyanates are self-emulsifying in water, which may be advantageous within the context of the present process since it may be possible to dispense with a separate emulsifying step. The weight ratio of the two isocyanates (A) and (B) is adjusted preferably in the range from 10:1 to 1 :10, but in particular in the range from 5:1 to 1 :5 and in particular in the range from 3:1 to 1 :1.
It is also possible to use mixtures of different isocyanates of types (A) and (B). Besides the isocyanates (A) and (B), further isocyanates can also additionally be used in the process according to the invention.
Preferably, however, only anionically modified isocyanates are used as component (B) in the present process.
Amines
At least difunctional amines, but preferably polyethyleneimines (PEI), are used as further component in the process according to the invention. Polyethyleneimines are generally polymers in the main chains of which there are NH groups which are separated from one another in each case by two methylene groups:
Figure imgf000009_0001
Polyethyleneimines belong to the polyelectrolytes and the complexing polymers. Short-chain, linear polyethyleneimines with a correspondingly high fraction of primary amino groups, i.e. products of the general formula H2N [CH2-CH2-NH]nH (n = 2: diethylenetriamine; n = 3; triethylenetetramine; n = 4: tetraethylenepentamine) are sometimes called polyethyleneamines or polyalkylenepolyamines.
In the processes according to the invention, polyethyleneimines with a molecular weight of at least 500 g/mol, preferably from 600 to 30 000 or 650 to 25 000 g/mol and in particular from 700 to 5000 g/mol or 850 to 2500 g/mol, are preferably used.
Protective colloids
In the process according to the invention, PVP is used as protective colloid. PVP is the abbreviation for polyvinylpyrrolidones (also known as polyvidone). According to Rompp Chemie Lexikon, Online-edition 3.6, 2010, they are [poly{1-vinylpyrrolidin- 2-ones)], i.e. polymers (vinyl polymers) which conform to the general formula:
Figure imgf000009_0002
Standard commercial polyvinylpyrrolidones have molar masses in the range from ca. 2500-750 000 g/mol which are characterized by stating the K values and have - depending on the K value - glass transition temperatures from 130 to 175°C. They are supplied as white, hygroscopic powders or as aqueous solution.
In the processes according to the invention, preference is given to using PVPs with a high molecular weight, i.e. more than 400 000 g/mol and preferably from
500 000 g/mol to 2 000 000 g/mol. It is furthermore preferred for the polyvinylpyrrolidones to have a K value of more than 60, preferably more than 75 and in particular more than 80. A preferred range is between 65 and 90 for the K value.
Fragrance Oil The microcapsules produced using the process described above contain a fragrance oil core. The isocyanates should be soluble in the oil forming the core
The term "fragrance oil" denotes one or a mixture of perfume components, optionally mixed with a suitable solvent, diluent, carrier or other adjuvant, which is intended to be used to impart a desired odour to a consumer product.
All manner of perfume ingredients may employed as will be clear to a person skilled in the art and it is not necessary to provide an exhaustive list here.
Exemplary of perfume components and mixtures thereof which can be used for the preparation of such fragrance oils may include natural products such as essential oils, absolutes, resinoids, resins, concretes, etc., and synthetic perfume
components such as hydrocarbons, alcohols, aldehydes, ketones, ethers, acids, esters, acetals, ketals, nitriles, etc., including saturated and unsaturated
compounds, aliphatic, carbocyclic and heterocyclic compounds. Examples of such perfume components are: geraniol, geranyl acetate, linalool, linalyl acetate, tetrahydrolinalool, citronelloi, citronellyl acetate, dihydromyrcenol, dihydromyrcenyl acetate, tetrahydromyrcenol, terpineol, terpinyl acetate, nopol, nopyl acetate, 2- phenylethanol, 2-phenylethyl acetate, benzyl alcohol, benzyl acetate, benzyl salicylate, benzyl benzoate, styrallyl acetate, amy! salicylate,
dimethylbenzylcarbinol, trichloromethylphenycarbinyl acetate, p-tert.butylcyclohexyl acetate, isononyl acetate, vetiveryl acetate, vetiverol, alpha-n-amylcinammic aldehyde, alpha-hexylcinammic aldehyde, 2-methyl-3-(p-tert.butylphenyl)propanal, 2-methyl-3-(p-isopropylphenyl)propanal, 3-(p-tert.butylphenyi)propanal,
tricyclodecenyl acetate, tricyclodecenyl propionate, 4-(4-hydroxy-4-methylpentyl)-3- cyclohexenecarbaldehyde, 4-(4-methyl-3-pentenyl)-3-cyclohexenecarba!dehyde, 4- acetoxy-3-pentyltetrahydropyran, methyl dihydrojasmonate, 2-n- heptylcyclopentanone, 3-methyl-2-pentylcyclopentanone, n-decanal, n-dodecanal, 9-decenol-1 , phenoxyethyl isobutyrate, phenylacetaldehyde dimethyl acetal, phenylacetaldehyde diethyl acetal, geranonitrile, citronellonitrile, cedryl acetate, 3- isocamphylcyclohexanol, cedryl methyl ether, isolongifolanone, aubepine nitrile, aubepine, heliotropine, coumarin, eugenol, vanillin, diphenyl oxide,
hydroxycitronellal, ionones, methyl ionones, isomethyl ionones, irones, cis-3- hexenol and esters thereof, indane musk fragrances, tetralin musk fragrances, isochroman musk fragrances, macrocyclic ketones, macrolactone musk
fragrances, ethylene brassylate, aromatic nitromusk fragrances. The fragrance oils may also contain precursor or pro-fragrances of any perfume ingredients including any of those mentioned specifically above.
Suitable solvents, diluents or carriers for perfumes as mentioned above are for example: ethanol, isopropanol, diethylene glycol monoethyl ether, dipropylene glycol, diethyl phthalate, triethyl citrate and the like. Examples of carrier materials, diluents, solvents and other auxiliary agents commonly used in conjunction with fragrance oils can be found in, for example, in S. Arctander, 'Perfume and Flavour Materials of Natural Origin', Elizabeth, N.J., 1960, S. Arctander, 'Perfume and Flavour Chemicals', Vol. I and II, Allured Publishing Corporation, Carol Stream, 1994, and J.M. Nikitakis (Ed.), 'CTFA Cosmetic Ingredient Handbook, 1st ed., The Cosmetic, Toiletry and Fragrance Association, Inc., Washington, 1988.
The invention further provides aqueous dispersions comprising 5 to 50% by weight, based on the total weight of the dispersion, preferably from 15 to 40% by weight, of microcapsules which can be produced by the above process. A further preferred range is between 20 and 35% by weight. These aqueous dispersions are
preferably obtained directly from the process described above.
The microcapsule dispersions which are obtained by the present process can be used to perfume all manner of consumer products. An exhaustive list of consumer products cannot be given here and the skilled person would appreciate the scope of application for such microcapsules. Illustrative examples of consumer products include all laundry applications including softeners, liquid detergents, and powder detergents; all personal care and hair care applications including shampoo, conditioners, combing creams, leave on conditioners, styling cream, soaps, body creams and the like; deodorants and anti-perspirants; and all household cleaning applications.
The present invention further provides preferably formaldehyde-free microcapsules containing a fragrance oil core, and a shell of a reaction product of at least two different at least difunctional isocyanates (A) and (B), where the isocyanate (B) must be an anionically modified isocyanate or a polyethylene oxide containing isocyanate or mixtures of the types, and an at least difunctional amine, with the proviso that during the production of the microcapsules the weight ratio between the isocyanates (A) and (B) is in the range from 10:1 to 1 :10. Preferably, the aforementioned weight ratios can be adjusted, where the ratio from 3:1 to 1 :1 may be attributed particular importance.
These microcapsules preferably have diameters from 1 to 50 μιη and preferably diameters from 2 to 45 μηι. They may be present in the form of an aqueous dispersion, where the fraction of the capsules can be 1 to 90% by weight, but preferably 5 to 50% by weight.
There now follows a series of examples that serve to illustrate the invention.
Example 1 - Encapsulation
An oil phase was prepared when Desmodur W (Bayer) and Bayhydur XP2547 (Bayer) were added in perfume oil at a level of 2.6% and 3.4% respectively. An aqueous phase (Solution S1) was prepared by adding Luviskol k90 (BASF) to water, at a level of 4.5%. The pH of the solution was adjusted at 10 by addition of a buffer pH=10 at 0.5%.
An aqueous phase (Solution S2) was prepared by adding Lupasol PR8515 (BASF) to water, at a level of 20%. Capsules were prepared according to the following procedure:
300g of the oil phase was mixed with 600g of solution S1 , to form an oil-in-water emulsion, in a 1L reactor equipped with a MIG stirrer operating at 10OOrpm.After 30 minutes of mixing, 10Og of solution S2 was added over a period of 1 minute.After 30 minutes, the slurry was heated up to 70°C (1 H), then kept for 2H at 70°C, then heated to 80°C and kept for 1 H at 80°C, then heated to 85°C and kept for 1 H at 85°C, then cooled to 70°C and kept for 1 H at 70°C before final cooling at 25°C.
Example 2 - Hair Care application
Hair Switch testing was carried out using standard hair protocols with a dosage of perfume of 0.2%. The capsules were prepared according to recipe given in example 1. The perfume composition is given in Table below. The performance of the capsules was evaluated by a direct comparison with the free perfume (non encapsulated oil).
%
AGRU EX 30
AMYL BUTYRATE 2.5
GALBANONE 10
ETHYL 2 METHYL
BUTYRATE 2.5
HEXYL ACETATE
NECTARYL
PECHE PURE 10
PRENYL ACETATE 6
TRIPLAL
VERDYL ACETATE 25 Protocol for shampoo
• Switches used: European hair, virgin, not damaged (but re-used several times)
• Dampen switch with warm water and place on weighing balance
· Squeeze 2.5 g of shampoo along the switch using a syringe
• Massage the shampoo into the hair switch for 30 seconds
• Leave the lathered switch to soak for 1 minute before rinsing out under running hand-hot water for approx. 30 seconds
• Squeeze the switch between two fingers to remove excess water
· Dry switch; either hang up to air dry or immediately blow dry using a hair dryer
• Leave air dried samples hanging in an odour free room for 24 hours
• Assess each switch before and after combing by use of a ten point scale:
0 = No odour, 9 = very strong
Protocol for Hair conditioner:
The same protocol was followed for conditioner except the hair switches are pre- washed in unfragranced shampoo before the conditioner is applied
Figure imgf000014_0001
Example 3 - Fabric Care Application The capsules were prepared according to recipe given in Example 1. The perfume composition is given in Table below. The performance of the capsules was evaluated by a direct comparison with the free perfume (non encapsulated oil), on freshly prepared samples and after 1 month storage at 37°C. %
AGRUMEX 30
AMYL BUTYRATE 2.5
GALBANONE 10
ETHYL 2 METHYL
BUTYRATE 2.5
HEXYL ACETATE 5
NECTARYL 5
PECHE PURE 10
PRENYL ACETATE 6
TR!PLAL 4
VERDYL ACETATE 25
Protocol for Fabric detergent application
Washing conditions: 100g of perfumed powder detergent, 1kg of cotton toweis, European washing machine. The perfumed samples were prepared at a level of 0.5% perfume in a standard powder detergent base and the washing conditions used were as follows:
- total weight of the wash was 1 kg
- European machines
- Assessment Is done before and after rubbing, on line dried and tumble dried towels, by use of a 5 point scale: 0 = no odour; 5 = very strong
Protocol for Fabric softener application The perfumed samples were prepared at a level of 0.5% perfume in a standard fabric conditioner base comprising 13% Quaternium ammonium ARQUAD 2HT75 from Akzo, 0.3% Silicone Dow Corning DB110 from Dow Corning, 0.6% CaCI2 from Merck and 0.15% Bronidoxfrom Henkel and the washing conditions used were as follow:
- total weight of the wash was 0.2kg
- wash with unperfumed laundry powder {90g of standard internal Givaudan laundry powder) done before adding 35g of the perfumed fabric conditioner
- European machines
- Assessment is done before and after rubbing, on line dried and tumble dried towels, by use of a 5 point scale: 0 = no odour; 5 = very strong
Performance in powder detergent {before / after rubbing)
Sample Freshly prepared After 1 month storage at 37°C
Line dried Tumble Line dried Tumble dried dried
Free oil 1 /1 0.5/0.5 0.5/0.5 0.5/0.5 capsule 2.5/3.5 3/3.5 1 /3 3/4
Performance in Fabric conditioner (before / after rubbing)
Sample Freshly prepared After 1 month storage at 37°C
Line dried Tumble dried Line dried Tumble dried
Free oil 1.5/1.5 1/1 1 Π 0.5/0.5 capsule 2/3.5 2/3 1/3.5 1.5/3.5

Claims

Claims
1. A consumer product selected from the group consisting of laundry
applications including softeners, liquid detergents, and powder detergents; personal care and hair care applications including shampoo, conditioners, combing creams, leave on conditioners, styling cream, soaps, body creams; deodorants and anti-perspirants; and household cleaning
applications, containing microcapsules comprising a fragrance oil core, and a shell of a reaction product of at least two different at least difunctional isocyanates (A) and (B), where the isocyanate (B) must be an anionically modified isocyanate or a polyethylene oxide-containing isocyanate or mixtures of these types, and an at least difunctional amine, with the proviso that during the production of the microcapsules the weight ratio between the isocyanates (A) and (B) is in the range from 10:1 to 1 :10.
2. A consumer product according to claim 1 wherein the microcapsule has a diameter from 1 to 50 μιτι.
3. A consumer product according to claim 1 or claim 2 wherein microcapsule is present in the form of an aqueous dispersion.
4. A consumer product according to any of the preceding claims wherein the microcapsules are produced by a process wherein an aqueous solution of a protective colloid and a solution of a mixture of at least two structurally different at least difunctional diisocyanates (A) and (B) in a fragrance oil are brought together until an emulsion is formed, to which an at least
difunctional amine is then added and which is then heated to temperatures of at least 60°C until the microcapsules are formed, wherein the isocyanate (B) is selected from the anionically modified isocyanates or the polyethylene oxide-containing isocyanates and the isocyanate (A) is uncharged and is not a polyethylene oxide-containing isocyanate.
5. A consumer product according to claim 4 wherein a polyvinylpyrrolidone is used as protective colloid.
6. . A consumer product according to claim 4 or claim 5 wherein the isocyanate (A) is selected from the group consisting of hexane 1 ,6-diisocyanate, hexane 1 ,6-diisocyanate biuret or oligomers of hexane 1 ,6-diisocyanate, in particular trimers thereof or dicyclohexanemethylene diisocyanate.
7. A consumer product according to any of the claims 4 to 6 wherein the
isocyanate (B) is selected from the group of anionically modified
diisocyanates which contain at least one sulfonic acid group, preferably an aminosulfonic acid group, in the molecule.
8. A consumer product according to any of the claims 4 to 7 wherein the at least difunctional amine used is a polyethyleneimine.
9. A consumer product according to any of the claims 4 to 8 wherein the weight ratio between the isocyanates (A) and (B) is in the range from 10:1 to 1 :10, preferably 5:1 to 1 :5 and in particular from 3:1 to 1 :1.
10. A consumer product according to any of the claims 4 to 9 wherein the core- shell ratio (w/w) of the microcapsules is 20:1 to 1 :10, preferably 5:1 to 2:1 and in particular 4:1 to 3:1.
11. A consumer product according to any of the claims 4 to 10 wherein the
process of forming the microcapsules proceeds according to the following steps: (a) a premix (I) is prepared from water and a protective colloid;
(b) this premix is adjusted to a pH in the range from 5 to 12;
(c) a further premix (II) is prepared from the fragrance oil together with the isocyanates (A) and (B);
(d) the two premixes (I) and (II) are brought together until an emulsion is formed and
(e) the at least difunctional amine is then metered into the emulsion from step (d) and (f) the emulsion is then heated to temperatures of at least 60°C until the microcapsules are formed.
A consumer product according to claim 1 wherein the pH in process step (b) is adjusted to 8 to 12.
The use of microcapsules as defined in any of the claims 1 to 12 for perfuming a consumer product selected from the group consisting of laundry applications including softeners, liquid detergents, and powder detergents; personal care and hair care applications including shampoo, conditioners, combing creams, leave on conditioners, styling cream, soaps, body creams; deodorants and anti-perspirants; and household cleaning applications.
PCT/EP2011/060599 2010-06-25 2011-06-24 Process for producing microcapsules WO2011161229A1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
MX2012013822A MX2012013822A (en) 2010-06-25 2011-06-24 Process for producing microcapsules.
JP2013515906A JP6078464B2 (en) 2010-06-25 2011-06-24 Method for producing microcapsules
BR112012033017-9A BR112012033017B1 (en) 2010-06-25 2011-06-24 Consumer product and use of microcapsules
EP11729951.1A EP2585028B1 (en) 2010-06-25 2011-06-24 Process for producing microcapsules
US13/699,419 US20130089590A1 (en) 2010-06-25 2011-06-24 Process for Producing Microcapsules
ES11729951.1T ES2602440T3 (en) 2010-06-25 2011-06-24 Procedure for the production of microcapsules
KR1020137001659A KR101833084B1 (en) 2010-06-25 2011-06-24 Process for producing microcapsules
CN201180028710XA CN102958497A (en) 2010-06-25 2011-06-24 Process for producing microcapsules
ZA2012/09124A ZA201209124B (en) 2010-06-25 2012-12-03 Process for producing microcapsules
US14/560,700 US20150140050A1 (en) 2010-06-25 2014-12-04 Process for Producing Microcapsules

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1010701.9A GB201010701D0 (en) 2010-06-25 2010-06-25 Process for producing microcapsules
GB1010701.9 2010-06-25

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US13/699,419 A-371-Of-International US20130089590A1 (en) 2010-06-25 2011-06-24 Process for Producing Microcapsules
US14/560,700 Continuation US20150140050A1 (en) 2010-06-25 2014-12-04 Process for Producing Microcapsules

Publications (1)

Publication Number Publication Date
WO2011161229A1 true WO2011161229A1 (en) 2011-12-29

Family

ID=42582979

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/060599 WO2011161229A1 (en) 2010-06-25 2011-06-24 Process for producing microcapsules

Country Status (11)

Country Link
US (2) US20130089590A1 (en)
EP (1) EP2585028B1 (en)
JP (1) JP6078464B2 (en)
KR (1) KR101833084B1 (en)
CN (2) CN106176326A (en)
BR (1) BR112012033017B1 (en)
ES (1) ES2602440T3 (en)
GB (1) GB201010701D0 (en)
MX (1) MX2012013822A (en)
WO (1) WO2011161229A1 (en)
ZA (1) ZA201209124B (en)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150049867A (en) * 2013-10-31 2015-05-08 (주)아모레퍼시픽 Composition comprising encapsulated fragrances
WO2015189309A1 (en) * 2014-06-13 2015-12-17 Firmenich Sa Process for preparing polyurea microcapsules with improved deposition
WO2016071152A1 (en) 2014-11-07 2016-05-12 Basf Se Process for preparing microcapsules having a polyurea shell and a lipophilic core material
WO2016071151A1 (en) 2014-11-07 2016-05-12 Givaudan Sa Capsule composition
WO2016071149A1 (en) 2014-11-07 2016-05-12 Givaudan Sa Improvements in or relating to organic compounds
EP3170552A1 (en) 2015-11-23 2017-05-24 Basf Se Microcapsule comprising a polymeric shell and a hydrophilic or hydrophobic core material
WO2017085033A1 (en) 2015-11-18 2017-05-26 Basf Se Improvements in or relating to organic compounds
WO2018030431A1 (en) 2016-08-09 2018-02-15 Takasago International Corporation Solid composition comprising free and encapsulated fragrances
WO2018050914A1 (en) * 2016-09-19 2018-03-22 Givaudan Sa Improvements in or relating to organic compounds
US10195577B2 (en) 2014-04-29 2019-02-05 Basf Se Process for producing microcapsules
US10201795B2 (en) 2014-11-07 2019-02-12 Basf Se Microcapsules comprising hydroxyalkyl cellulose
WO2018050899A3 (en) * 2016-09-19 2019-04-25 S.P.C.M. Sa Use of an ampholyte copolymer as colloidal stabilizer in a process of encapsulating fragrance
WO2019174978A1 (en) * 2018-03-14 2019-09-19 Givaudan Sa Improvements in or relating to organic compounds
WO2021037703A1 (en) 2019-08-29 2021-03-04 Givaudan Sa Improvements in or relating to organic compounds
EP3845304A1 (en) 2019-12-30 2021-07-07 Bayer AG Capsule suspension concentrates based on polyisocyanates and biodegradable amine based cross-linker
WO2021260017A1 (en) 2020-06-26 2021-12-30 Bayer Aktiengesellschaft Aqueous capsule suspension concentrates comprising biodegradable ester groups
WO2022029490A1 (en) 2020-08-06 2022-02-10 Symrise Ag Process for the preparation of microcapsules
US11364184B2 (en) 2015-07-17 2022-06-21 Givaudan Sa Perfume compositions
WO2023111164A1 (en) 2021-12-15 2023-06-22 Givaudan Sa Improvements in or relating to organic compounds
WO2023148253A1 (en) 2022-02-02 2023-08-10 Symrise Ag Method for producing microcapsules
WO2023147889A1 (en) 2022-02-02 2023-08-10 Symrise Ag Process for producing microcapsules

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160075976A1 (en) * 2013-05-03 2016-03-17 Novozymes A/S Microencapsulation of Detergent Enzymes
BR112016017264B1 (en) * 2014-01-27 2021-09-08 Firmenich Sa PROCESS FOR PREPARING AMINOPLASTIC MICROCAPSULAS
EP3368207B1 (en) 2015-10-27 2021-12-01 Encapsys, LLC Encapsulation
SG11201803900UA (en) * 2015-12-15 2018-06-28 Firmenich & Cie Process for preparing polyurea microcapsules with improved deposition
CA3046510A1 (en) 2017-01-27 2018-08-02 Encapsys, Llc Encapsulates
WO2019206404A1 (en) * 2018-04-24 2019-10-31 Symrise Ag Core-shell capsules prepared with linear and cyclic aliphatic polyisocyanates
CN109568154A (en) * 2018-12-28 2019-04-05 北京航洋健康科技有限公司 A kind of capsule housing and the fragrant soft capsule of lock prepared therefrom and preparation method thereof
CN111389315A (en) * 2020-03-27 2020-07-10 南京芬之怡生物科技有限公司 Green impurity-removing purifying agent and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011885A (en) * 1989-10-27 1991-04-30 The Mead Corporation Methods for the production of microcapsules using functionalized isocyanate
US5342556A (en) * 1991-09-16 1994-08-30 Bayer Aktiengesellschaft Microcapsules made of isocyanates with groups containing polyethylene oxide

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886085A (en) * 1971-08-31 1975-05-27 Fuji Photo Film Co Ltd Process for producing fine oil-containing microcapsules having strong protective shells and microcapsules produced thereby
US4643764A (en) * 1984-01-09 1987-02-17 Stauffer Chemical Company Multiple types of microcapsules and their production
JPH069650B2 (en) * 1985-11-26 1994-02-09 エヌオーケー株式会社 Method for producing sustained-release microcapsules
FR2591124B1 (en) * 1985-12-10 1988-02-12 Rhone Poulenc Spec Chim POLYADDITION-INTERFACIAL MICROENCAPSULATION PROCESS.
US5225118A (en) * 1990-08-15 1993-07-06 Boise Cascade Corporation Process for manufacturing polyurea microcapsules and product therefrom
JP3186783B2 (en) * 1991-03-05 2001-07-11 日華化学株式会社 Manufacturing method of microcapsules
JPH06362A (en) * 1992-06-23 1994-01-11 Lion Corp Production of microcapsules
JP3518921B2 (en) * 1995-03-28 2004-04-12 三井化学株式会社 Microcapsule and method for producing the same
US7871636B2 (en) * 2003-04-14 2011-01-18 Basf Aktiengesellschaft Aqueous, flowable concentrate composition of pendimethalin
CA2525263A1 (en) * 2003-05-11 2004-11-18 Ben Gurion University Of The Negev Research And Development Authority Encapsulated essential oils
JP2006021164A (en) * 2004-07-09 2006-01-26 Mitsubishi Chemicals Corp Super-fine micro capsule, production method therefor and recording liquid using the same
CN101056700A (en) * 2004-11-05 2007-10-17 巴斯福股份公司 Microcapsule dispersions
JP4740801B2 (en) * 2006-06-28 2011-08-03 ライオン株式会社 Liquid finish composition for textile products
JP5213040B2 (en) * 2008-09-30 2013-06-19 大日本塗料株式会社 Method for producing dispersion
EP2379047B1 (en) * 2008-12-18 2017-03-15 Firmenich S.A. Microcapsules and uses thereof
CA2744606C (en) * 2008-12-19 2016-11-08 Basf Se Aqueous flowable concentrate compositions of a microencapsulated dinitroaniline herbicide
US8299011B2 (en) * 2009-09-18 2012-10-30 International Flavors & Fragrances Inc. Encapsulated active materials
CN103140208A (en) * 2010-06-25 2013-06-05 奇华顿股份有限公司 Encapsulated compositions comprising aldehyde fragrance precursors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011885A (en) * 1989-10-27 1991-04-30 The Mead Corporation Methods for the production of microcapsules using functionalized isocyanate
US5342556A (en) * 1991-09-16 1994-08-30 Bayer Aktiengesellschaft Microcapsules made of isocyanates with groups containing polyethylene oxide

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"CTFA Cosmetic Ingredient HandbooK", 1988, THE COSMETIC, TOILETRY AND FRAGRANCE ASSOCIATION, INC.
ELIZABETH, N.J., S. ARCTANDER: "Perfume and Flavour Chemicals", vol. I, II, 1960, ALLURED PUBLISHING CORPORATION
S. ARCTANDER, PERFUME AND FLAVOUR MATERIALS OF NATURAL ORIGIN

Cited By (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150049867A (en) * 2013-10-31 2015-05-08 (주)아모레퍼시픽 Composition comprising encapsulated fragrances
KR102063027B1 (en) 2013-10-31 2020-01-07 (주)아모레퍼시픽 Composition comprising encapsulated fragrances
US10195577B2 (en) 2014-04-29 2019-02-05 Basf Se Process for producing microcapsules
WO2015189309A1 (en) * 2014-06-13 2015-12-17 Firmenich Sa Process for preparing polyurea microcapsules with improved deposition
US10508253B2 (en) 2014-06-13 2019-12-17 Firmenich Sa Process for preparing polyurea microcapsules with improved deposition
US20170121649A1 (en) * 2014-06-13 2017-05-04 Firmenich Sa Process for preparing polyurea microcapsules with improved deposition
WO2016071151A1 (en) 2014-11-07 2016-05-12 Givaudan Sa Capsule composition
WO2016071149A1 (en) 2014-11-07 2016-05-12 Givaudan Sa Improvements in or relating to organic compounds
US10307723B2 (en) 2014-11-07 2019-06-04 Basf Se Process for preparing microcapsules having a polyurea shell and a lipophilic core material
US10398632B2 (en) 2014-11-07 2019-09-03 Givaudan S.A. Capsule composition
WO2016071152A1 (en) 2014-11-07 2016-05-12 Basf Se Process for preparing microcapsules having a polyurea shell and a lipophilic core material
US10201795B2 (en) 2014-11-07 2019-02-12 Basf Se Microcapsules comprising hydroxyalkyl cellulose
US11364184B2 (en) 2015-07-17 2022-06-21 Givaudan Sa Perfume compositions
WO2017085033A1 (en) 2015-11-18 2017-05-26 Basf Se Improvements in or relating to organic compounds
US11077417B2 (en) 2015-11-23 2021-08-03 Basf Se Microcapsule comprising a polyester-urethane shell and a hydrophobic core material
WO2017089116A1 (en) 2015-11-23 2017-06-01 Basf Se Microcapsule comprising a polyester-urethane shell and a hydrophobic core material
EP3170552A1 (en) 2015-11-23 2017-05-24 Basf Se Microcapsule comprising a polymeric shell and a hydrophilic or hydrophobic core material
WO2017089115A1 (en) 2015-11-23 2017-06-01 Basf Se Microcapsule comprising a polyester-urethane shell and a hydrophilic core material
US10695734B2 (en) 2015-11-23 2020-06-30 Basf Se Microcapsule comprising a polyester-urethane shell and a hydrophilic core material
WO2018030431A1 (en) 2016-08-09 2018-02-15 Takasago International Corporation Solid composition comprising free and encapsulated fragrances
US20190233770A1 (en) * 2016-09-19 2019-08-01 Givaudan Sa Improvements in or relating to organic compounds
WO2018050914A1 (en) * 2016-09-19 2018-03-22 Givaudan Sa Improvements in or relating to organic compounds
US10758885B2 (en) 2016-09-19 2020-09-01 S.P.C.M. Sa Use of an ampholyte copolymer as colloidal stabilizer in a process of encapsulating fragrance
US10808208B2 (en) 2016-09-19 2020-10-20 Givaudan Sa Organic compounds
WO2018050899A3 (en) * 2016-09-19 2019-04-25 S.P.C.M. Sa Use of an ampholyte copolymer as colloidal stabilizer in a process of encapsulating fragrance
US11351096B2 (en) 2018-03-14 2022-06-07 Givaudan Sa Organic compounds
WO2019174978A1 (en) * 2018-03-14 2019-09-19 Givaudan Sa Improvements in or relating to organic compounds
WO2021037703A1 (en) 2019-08-29 2021-03-04 Givaudan Sa Improvements in or relating to organic compounds
WO2021136758A1 (en) 2019-12-30 2021-07-08 Bayer Aktiengesellschaft Aqueous capsule suspension concentrates based on polyurea shell material containing polyfunctional aminocarboxylic esters
EP3845304A1 (en) 2019-12-30 2021-07-07 Bayer AG Capsule suspension concentrates based on polyisocyanates and biodegradable amine based cross-linker
WO2021260017A1 (en) 2020-06-26 2021-12-30 Bayer Aktiengesellschaft Aqueous capsule suspension concentrates comprising biodegradable ester groups
WO2022029490A1 (en) 2020-08-06 2022-02-10 Symrise Ag Process for the preparation of microcapsules
WO2023111164A1 (en) 2021-12-15 2023-06-22 Givaudan Sa Improvements in or relating to organic compounds
WO2023148253A1 (en) 2022-02-02 2023-08-10 Symrise Ag Method for producing microcapsules
WO2023147889A1 (en) 2022-02-02 2023-08-10 Symrise Ag Process for producing microcapsules
WO2023147855A2 (en) 2022-02-02 2023-08-10 Symrise Ag Process for producing microcapsules

Also Published As

Publication number Publication date
EP2585028A1 (en) 2013-05-01
US20130089590A1 (en) 2013-04-11
EP2585028B1 (en) 2016-08-10
KR20130122930A (en) 2013-11-11
MX2012013822A (en) 2013-01-28
ZA201209124B (en) 2016-07-27
US20150140050A1 (en) 2015-05-21
JP2013534952A (en) 2013-09-09
GB201010701D0 (en) 2010-08-11
ES2602440T3 (en) 2017-02-21
CN102958497A (en) 2013-03-06
JP6078464B2 (en) 2017-02-08
BR112012033017A2 (en) 2017-04-04
KR101833084B1 (en) 2018-02-27
BR112012033017B1 (en) 2018-01-09
CN106176326A (en) 2016-12-07

Similar Documents

Publication Publication Date Title
EP2585028B1 (en) Process for producing microcapsules
JP6082143B2 (en) Beneficial agent delivery particles, methods for preparing the particles, compositions containing the particles and methods for treating the substrate
JP7200250B2 (en) Encapsulated perfume compositions and methods for their preparation
US10682533B2 (en) Multi-capsule compositions
EP3459622B1 (en) Encapsulated active material
US20040087477A1 (en) Perfume encapsulates
US20230136124A1 (en) Core-Shell Microcapsule with a Polyamine-Based Thermosetting Shell
EP3515589B1 (en) Improvements in or relating to organic compounds
RU2774912C2 (en) Encapsulated perfume composition and its production method
JP2022546957A (en) Improvements in or Related to Organic Compounds
CN113260450A (en) Microencapsulation of fragrances

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201180028710.X

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11729951

Country of ref document: EP

Kind code of ref document: A1

REEP Request for entry into the european phase

Ref document number: 2011729951

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2011729951

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 13699419

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: MX/A/2012/013822

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 2013515906

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 10655/CHENP/2012

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 1201006671

Country of ref document: TH

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20137001659

Country of ref document: KR

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112012033017

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112012033017

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20121221